EnsoData develops AI-powered software solutions to advance sleep medicine and support the full sleep care continuum from diagnosis through long-term patient management. Its flagship product, EnsoHST, is a clinically proven multi-night home sleep testing solution that uses a wearable device and mobile app to deliver fast, clinically reliable results. The company emphasizes automation of analysis and reduction of operational friction to help clinicians expand capacity and accelerate diagnosis. EnsoData reports its technology has supported care for more than 2.9 million patients. The company is exploring applications across additional clinical areas and plans to invest further in AI-driven innovations. The announcement was issued from Madison, Wis.

Total raised

$31M

Funding rounds

5

Latest round

Series A

Latest activity

Jun 2022